IN8BIO, INC. Depreciation
IN8BIO, INC. (INAB) reported Depreciation of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- IN8BIO, INC. depreciation for the quarter ending 2026-06-30 was $300.00K, a 0.00% change year-over-year.
- IN8BIO, INC. depreciation for the quarter ending 2026-03-31 was $245.00K, a 4.30% decline year-over-year.
- IN8BIO, INC. depreciation for the quarter ending 2025-12-31 was $245.00K, a 2.39% decline year-over-year.
- IN8BIO, INC. depreciation for the quarter ending 2025-09-30 was $200.00K, a 33.33% decline year-over-year.
- IN8BIO, INC. depreciation for fiscal 2025 was $1.00M, a 2.46% increase from fiscal 2024.
- IN8BIO, INC. depreciation for fiscal 2024 was $976.00K, a 1.46% increase from fiscal 2023.
- IN8BIO, INC. depreciation for fiscal 2023 was $962.00K, a 554.42% increase from fiscal 2022.
- IN8BIO, INC. depreciation for fiscal 2022 was $147.00K, a 65.17% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-06 | $500.00K 10-Q · filed 2026-08-06 | $790.00K derived: sum of 3 quarters · filed 2026-08-06 | $990.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $245.00K 10-Q · filed 2026-05-07 | $490.00K derived: sum of 2 quarters · filed 2026-05-07 | $690.00K derived: sum of 3 quarters · filed 2026-05-07 | $990.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $445.00K derived: sum of 2 quarters · filed 2026-03-12 | $745.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.00M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 | $500.00K derived: sum of 2 quarters · filed 2026-08-06 | $755.00K 10-Q · filed 2025-11-06 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-06 | $511.00K 10-Q · filed 2026-08-06 | $807.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.11M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $256.00K 10-Q · filed 2026-05-07 | $507.00K derived: sum of 2 quarters · filed 2026-05-07 | $807.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.01M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $551.00K derived: sum of 2 quarters · filed 2026-03-12 | $751.00K derived: sum of 3 quarters · filed 2026-03-12 | $976.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $300.00K 10-Q · filed 2025-11-06 | $500.00K derived: sum of 2 quarters · filed 2025-11-06 | $725.00K 10-Q · filed 2025-11-06 | $976.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-07 | $473.00K 10-Q · filed 2025-08-07 | $676.00K derived: sum of 3 quarters · filed 2025-08-07 | $976.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $239.00K 10-Q · filed 2025-05-07 | $476.00K derived: sum of 2 quarters · filed 2025-05-07 | $776.00K derived: sum of 3 quarters · filed 2025-05-07 | $976.00K derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $537.00K derived: sum of 2 quarters · filed 2025-03-13 | $737.00K derived: sum of 3 quarters · filed 2025-03-13 | $962.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $300.00K 10-Q · filed 2024-11-12 | $200.00K 10-Q · filed 2023-11-09 | $500.00K derived: sum of 2 quarters · filed 2024-11-12 | $725.00K 10-Q · filed 2024-11-12 | $819.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-08 | $243.00K 10-Q · filed 2023-08-10 | $486.00K 10-Q · filed 2024-08-08 | $519.00K derived: sum of 3 quarters · filed 2024-08-08 | $552.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $243.00K 10-Q · filed 2024-05-09 | $319.00K derived: sum of 2 quarters · filed 2024-05-09 | $352.00K derived: sum of 3 quarters · filed 2024-05-09 | $374.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $109.00K derived: sum of 2 quarters · filed 2024-03-14 | $131.00K derived: sum of 3 quarters · filed 2024-03-14 | $147.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $33.00K 10-Q · filed 2023-11-09 | $55.00K derived: sum of 2 quarters · filed 2023-11-09 | $71.00K 10-Q · filed 2023-11-09 | $93.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $22.00K 10-Q · filed 2023-08-10 | $38.00K 10-Q · filed 2023-08-10 | $60.00K derived: sum of 3 quarters · filed 2023-08-10 | $82.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-12 | $38.00K derived: sum of 2 quarters · filed 2023-05-12 | $60.00K derived: sum of 3 quarters · filed 2023-05-12 | $82.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $44.00K derived: sum of 2 quarters · filed 2023-03-30 | $66.00K derived: sum of 3 quarters · filed 2023-03-30 | $89.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $22.00K 10-Q · filed 2022-11-10 | $44.00K derived: sum of 2 quarters · filed 2022-11-10 | $67.00K 10-Q · filed 2022-11-10 | $88.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $22.00K 10-Q · filed 2022-08-12 | $44.00K 10-Q · filed 2022-08-12 | $66.00K derived: sum of 3 quarters · filed 2022-08-12 | $88.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-12 | $44.00K derived: sum of 2 quarters · filed 2022-05-12 | $66.00K derived: sum of 3 quarters · filed 2022-05-12 | $88.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $44.00K derived: sum of 2 quarters · filed 2022-03-17 | $66.00K derived: sum of 3 quarters · filed 2022-03-17 | $88.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $22.00K 10-Q · filed 2021-11-10 | $44.00K derived: sum of 2 quarters · filed 2021-11-10 | $66.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $22.00K 10-Q · filed 2021-09-10 | $44.00K 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |